Leukemia & lymphomaHumansQuality of LifeMaleFemaleMiddle Aged
Factors associated with long-term quality of life after allogenic stem cell transplantation.
Juan J Domínguez-García, Miriam Sánchez Escamilla, Sara García-Ávila, Brenda López Pereira, Guillermo Martín Sánchez, Miguel Á Cortés Vázquez, José A Calvo Sánchez, Sergio Fernández García, Leddy P Vega Suárez, Enrique M Ocio San Miguel, Maria A Bermúdez Rodríguez, Lucrecia Yáñez San Segundo
Published: 202510.1080/10428194.2025.2564769
Abstract
Allo-HSCT is a potentially curative treatment for hematologic diseases, but long-term quality of life (QoL) remains a concern. Factors like GVHD, comorbidities, and post-transplant complications can impact survivorship. Understanding QoL in long-term…
Preview only. Read the full abstract at the source